Peptilogics is a clinical-stage therapeutics company that develops peptide-based therapeutics using AI and computational biology.
Peptilogics has raised $78.0M in total funding. The most recent round was Series B. The last funding was announced in October 2025.
Peptilogics's investors include Founders Fund, Presight Capital, Narya Capital, Innovation Works, AAF Management Ltd..
Peptilogics is headquartered in Pittsburgh, United States.
Peptilogics is a clinical-stage therapeutics company that develops peptide-based therapeutics using AI and computational biology.
Peptilogics is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Peptilogics — Funding & Investors." VCBacked, October 16, 2025, https://www.vcbacked.co/company/peptilogics. Accessed July 19, 2026.
VCBacked. (2025). Peptilogics — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/peptilogics
{{cite web |title=Peptilogics — Funding & Investors |url=https://www.vcbacked.co/company/peptilogics |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated